Shingrix shingles vaccine
Selected indexed studies
- Shingrix: A New Vaccine for Shingles. (, 1994) [PMID:38620442]
- Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure. (Clin Infect Dis, 2021) [PMID:33580242]
- Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. (N Engl J Med, 2015) [PMID:25916341]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Shingrix: A New Vaccine for Shingles. (1994) pubmed
- Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure. (2021) pubmed
- Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. (2015) pubmed
- Herpes Zoster Vaccines. (2021) pubmed
- Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine. (2019) pubmed
- Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. (2016) pubmed
- Herpes Zoster Recurrence: A Narrative Review of the Literature. (2024) pubmed
- Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review. (2022) pubmed
- A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations. (2021) pubmed
- Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine. (2018) pubmed